Coherus BioSciences, Inc. (CHRS) Social Stream
COHERUS BIOSCIENCES INC (CHRS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CHRS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 6 | $30 | $19 | $24.666 | $2.13 | 1058.03% |
| 2022-01-27 | 6 | $30 | $16 | $24.166 | $2.13 | 1034.55% |
| 2022-02-18 | 6 | $30 | $16 | $23.666 | $2.13 | 1011.08% |
| 2022-02-22 | 6 | $30 | $15 | $23.5 | $2.13 | 1003.29% |
| 2022-03-07 | 6 | $30 | $15 | $22.666 | $2.13 | 964.13% |
| 2022-03-30 | 5 | $30 | $15 | $22.833 | $2.13 | 971.97% |
| 2022-04-13 | 5 | $30 | $15 | $22.666 | $2.13 | 964.13% |
| 2022-05-09 | 4 | $30 | $13 | $20.2 | $2.13 | 848.36% |
| 2022-05-20 | 4 | $30 | $13 | $21 | $2.13 | 885.92% |
| 2022-06-03 | 6 | $30 | $13 | $20.428 | $2.13 | 859.06% |
| 2022-08-01 | 6 | $30 | $7 | $18.5 | $2.13 | 768.54% |
| 2022-10-14 | 7 | $30 | $7 | $19.125 | $2.13 | 797.89% |
| 2022-11-09 | 6 | $30 | $7 | $19 | $2.13 | 792.02% |
| 2022-11-14 | 7 | $30 | $7 | $18.75 | $2.13 | 780.28% |
| 2022-11-16 | 7 | $30 | $7 | $17.875 | $2.13 | 739.2% |
| 2022-11-18 | 7 | $30 | $7 | $17.625 | $2.13 | 727.46% |
| 2022-12-16 | 7 | $30 | $7 | $17.375 | $2.13 | 715.73% |
| 2023-02-24 | 7 | $30 | $7 | $17.25 | $2.13 | 709.86% |
| 2023-03-07 | 7 | $30 | $7 | $16.625 | $2.13 | 680.52% |
| 2023-03-08 | 8 | $30 | $7 | $16.375 | $2.13 | 668.78% |
| 2023-03-14 | 8 | $30 | $7 | $16.625 | $2.13 | 680.52% |
| 2023-04-17 | 8 | $26 | $9 | $15.285 | $2.13 | 617.61% |
| 2023-04-24 | 9 | $30.001 | $9 | $17.125 | $2.13 | 703.99% |
| 2023-05-08 | 9 | $30.001 | $9 | $17.889 | $2.13 | 739.86% |
| 2023-05-10 | 9 | $30.001 | $9 | $17.555 | $2.13 | 724.18% |
| 2023-05-17 | 9 | $24 | $9 | $15.555 | $2.13 | 630.28% |
| 2023-05-23 | 9 | $24 | $8 | $15 | $2.13 | 604.23% |
| 2023-05-25 | 8 | $24 | $8 | $14.888 | $2.13 | 598.97% |
| 2023-06-06 | 9 | $24 | $8 | $14.888 | $2.13 | 598.97% |
| 2023-06-20 | 7 | $24 | $8 | $13.428 | $2.13 | 530.42% |
| 2023-07-14 | 7 | $24 | $8 | $14 | $2.13 | 557.28% |
| 2023-07-18 | 8 | $24 | $8 | $14 | $2.13 | 557.28% |
| 2023-07-24 | 9 | $24 | $8 | $13.75 | $2.13 | 545.54% |
| 2023-08-04 | 9 | $20 | $7 | $13.125 | $2.13 | 516.2% |
| 2023-10-12 | 9 | $20 | $6 | $13 | $2.13 | 510.33% |
| 2023-10-23 | 9 | $20 | $6 | $12.875 | $2.13 | 504.46% |
| 2023-10-30 | 9 | $20 | $6 | $13.125 | $2.13 | 516.2% |
| 2023-11-07 | 9 | $15 | $4 | $11 | $2.13 | 416.43% |
| 2023-11-08 | 9 | $15 | $4 | $11 | $2.13 | 416.43% |
| 2023-11-10 | 9 | $15 | $4 | $10.625 | $2.13 | 398.83% |
The Trend in the Analyst Price Target
Over the past 27 weeks, CHRS's average price target has gone down $7.46.
Over the past 47 weeks, CHRS's average upside potential has been 208.23%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 7 | 30 | 7 | 17.250 | 8.34 | 106.83% |
| 2023-02-24 | 6 | 30 | 7 | 17.250 | 6.94 | 148.56% |
| 2023-04-17 | 8 | 30 | 9 | 17.125 | 8.23 | 108.08% |
| 2023-07-18 | 8 | 24 | 8 | 14.000 | 4.39 | 218.91% |
| 2023-08-03 | 9 | 20 | 7 | 13.125 | 5.11 | 156.85% |
CHRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 6 | 0 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 19 months, CHRS's average broker recommendation rating improved by 0.13.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how COHERUS BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 5015.25% of that group.
- In the context of all US stocks, COHERUS BIOSCIENCES INC's variance in analysts' estimates is lower than -4464% of them.
- COHERUS BIOSCIENCES INC's number of analysts covering the stock is greater than 4235.35% of stocks in the small market cap category.
- In the context of Healthcare stocks, COHERUS BIOSCIENCES INC's average analyst price target is greater than 1638.1% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COHERUS BIOSCIENCES INC are ATRA, CGEN, and ONVO.
View All Top Stocks by Price Target
Make investment decisions regarding CHRS using the data that counts. Try POWR Ratings for free.